Please wait...
About This Project
We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.
Recent Lab Notes From This Project

Browse Other Projects on Experiment
Related Projects
Saving lives with synthetic antivenoms: looking for novel solutions to Lonomia envenoming in Colombia
Venomous caterpillars of the genus Lonomia cause deadly accidents in Colombia. In Brazil it is estimated...
Exploring an age-old question: Can we demystify skin color?
In 2005, our lab uncovered one of the most pervasive genetic mutations on SLC24A5, the contributor to the...
Will This Mobile Resource Help Healthcare Professionals Prescribe Antidepressants?
Understanding pharmacological agents is key to treatment selection. For the increasing involvement of primary...